American Century Companies Inc Arcellx, Inc. Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 29,446 shares of ACLX stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,446Holding current value
$1.86 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACLX
# of Institutions
222Shares Held
45.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$253 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$246 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$237 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$222 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$210 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.77B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...